Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 6,700 shares at $15.64 ($105K) on 2007-01-03, disclosed to the SEC on 2007-01-04.
Scheduled sale ($105k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.38 | 600 | $9K | 8.8% |
| 2 | $15.39 | 500 | $8K | 7.3% |
| 3 | $15.40 | 200 | $3K | 2.9% |
| 4 | $15.45 | 100 | $2K | 1.5% |
| 5 | $15.46 | 100 | $2K | 1.5% |
| 6 | $15.48 | 200 |
| $3K |
| 3.0% |
| 7 | $15.50 | 200 | $3K | 3.0% |
| 8 | $15.52 | 100 | $2K | 1.5% |
| 9 | $15.53 | 200 | $3K | 3.0% |
| 10 | $15.54 | 300 | $5K | 4.4% |
| 11 | $15.55 | 300 | $5K | 4.5% |
| 12 | $15.58 | 100 | $2K | 1.5% |
| 13 | $15.59 | 300 | $5K | 4.5% |
| 14 | $15.60 | 200 | $3K | 3.0% |
| 15 | $15.64 | 100 | $2K | 1.5% |
| 16 | $15.69 | 100 | $2K | 1.5% |
| 17 | $15.70 | 100 | $2K | 1.5% |
| 18 | $15.75 | 100 | $2K | 1.5% |
| 19 | $15.76 | 500 | $8K | 7.5% |
| 20 | $15.77 | 400 | $6K | 6.0% |
| 21 | $15.78 | 200 | $3K | 3.0% |
| 22 | $15.80 | 100 | $2K | 1.5% |
| 23 | $15.81 | 400 | $6K | 6.0% |
| 24 | $15.82 | 100 | $2K | 1.5% |
| 25 | $15.87 | 500 | $8K | 7.6% |
| 26 | $15.88 | 300 | $5K | 4.5% |
| 27 | $15.89 | 100 | $2K | 1.5% |
| 28 | $15.92 | 100 | $2K | 1.5% |
| 29 | $15.94 | 100 | $2K | 1.5% |
| 30 | $15.99 | 100 | $2K | 1.5% |
| Total | $15.64 avg | 6,700 | $105K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |